Taylor, MckenzieTran, Stephanie2022-08-232022-08-232019-04-102019-07-3110.13028/dc3p-8349https://hdl.handle.net/20.500.14038/27011<p>Blog post to Commonwealth Medicine's website - <a href="https://commed.umassmed.edu/blog/2019/04/10/will-ending-certain-drug-rebates-lower-list-prices-and-patient-out-pocket-costs" target="_blank">view blog post online</a></p>Earlier this year, the Department of Health and Human Services (HHS) proposed changes to the current pricing and contracting system for federal health care programs, Medicare Part D and Medicaid.This proposal aligns with the Trump Administration’s blueprint for lowering drug prices which we have written about previously.en-US© 2019 University of Massachusetts Medical Schoolprescription drug rebateslist pricespatientsout-of-pocket costsdrug companiespharmacy benefit managersHealth EconomicsHealth Law and PolicyHealth PolicyHealth Services AdministrationHealth Services ResearchPharmacy Administration, Policy and RegulationWill ending certain drug rebates lower list prices and patient out-of-pocket costs?Blog Posthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1235&context=commed_pubs&unstamped=1https://escholarship.umassmed.edu/commed_pubs/23715028679commed_pubs/237